Navigation Links
Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV
Date:10/29/2009

1, 2008 and the Quarterly Report on Form 10-Q for the quarter ended June 30, 2009, as filed with the Securities and Exchange Commission (SEC) and other filings that the company makes with the SEC.

All forward-looking statements reflect the company's expectations only as of the date of this release and should not be relied upon as reflecting the company's views, expectations or beliefs at any date subsequent to the date of this release. Idenix anticipates that subsequent events and developments may cause these views, expectations and beliefs to change. However, while Idenix may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. 

    Idenix Pharmaceuticals Contact:
    Teri Dahlman (617) 995-9905

SOURCE Idenix Pharmaceuticals, Inc.


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Idenix Announces Data Presentations at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
2. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
3. Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock
4. Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results
5. Idenix to Host Conference Call Discussing Second Quarter 2009 Financial Results
6. Idenix Pharmaceuticals to Present at The Deutsche Bank 2009 Health Care Conference
7. Idenix Pharmaceuticals Reports First Quarter Financial Results
8. Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver
9. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
10. Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)
11. Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2012)... A team of Australian scientists has identified new ... with bowel cancer. The discovery has the potential ... the early stages of bowel cancer. This test could potentially ... encouraging those at risk to have a colonoscopy. ... at a major medical conference in the United States - ...
(Date:5/18/2012)... May 18, 2012 Sequenom, Inc. (NASDAQ: ... genetic analysis solutions, today announced that a new publication ... on the Sequenom Center for Molecular Medicine,s (Sequenom CMM) ... published online in the peer-reviewed journal, Prenatal Diagnosis ... that as of the week ended May 12, 2012, ...
(Date:5/17/2012)... effort to voice concern on biosimilars pathways for patients ... (IDF) offered oral testimony at last week,s ... draft guidance of biosimilars products. IDF urged the FDA ... in order to protect the safety of patients with ... with an immune system that is either absent or ...
(Date:5/16/2012)... was able to reach for and sip from a drink ... 15 years by using her thoughts to direct a ... National Institutes of Health, is evaluating the safety and feasibility ... This is a type of brain-computer interface (BCI) intended ... control. , A report published today in Nature ...
Breaking Biology Technology:Australian Discovered Biomarkers Map Path to New Blood Test for Bowel Cancer 2Australian Discovered Biomarkers Map Path to New Blood Test for Bowel Cancer 3Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 2Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 3Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 4Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 5Immune Deficiency Foundation Urges FDA To Exempt Immunoglobulin From Biosimilars Pathway 2Paralyzed individuals use thought-controlled robotic arm to reach and grasp 2Paralyzed individuals use thought-controlled robotic arm to reach and grasp 3Paralyzed individuals use thought-controlled robotic arm to reach and grasp 4Paralyzed individuals use thought-controlled robotic arm to reach and grasp 5
... Neurological Function Now Available in the US, ... a new product called NeuroAid10(TM) in the US ... from,NeuroAid(TM) and is a combination of ten all-natural ... together the best of Asian,and Western medicine., ...
... Calif., March 6 Senetek PLC (OTC,Bulletin Board: ... development,of technologies that target the science of healthy ... two Veteran Sales and Marketing Executives,and the appointment ... Campagnoli joined the Company in December and has ...
... Inc., a,biodefense company specializing in the development and ... announced,today that it has completed the initial pharmacokinetic ... nerve agent prophylaxis., The PK studies were ... final,pegylated version of rBChE for the first time. ...
Other Biology Technology:Moleac Launches NeuroAid10(TM) in the United States 2Moleac Launches NeuroAid10(TM) in the United States 3Senetek PLC Announces Appointments of Key Personnel 2Senetek PLC Announces Appointments of Key Personnel 3PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008 2PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008 3PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008 4
(Date:5/21/2012)... US scientists has found there has been a massive ... off the coast of Antarctica.,Comparing detailed measurements taken during ... voyage to historical data dating back to 1970, scientists ... per cent reduction in the volume of Antarctic Bottom ... currents. , In an intensive and arduous 25-day observing ...
(Date:5/20/2012)... ARLINGTON, VA (May 14, 2012) - ... groundbreaking research being unveiled at the American Association ... The conference takes place Monday, May 21 - ... Hotel and Marina. Other topics to be discussed ... and tech transfer strategies, applications of multi-scale systems ...
(Date:5/20/2012)... uses a trial-and-error process to mimic the song of its ... times a day, making subtle changes in the pitch of ... process begins around the age of 40 days and is ... and ready to use his song to woo females. , ... process large quantities of information about its performance and use ...
Breaking Biology News(10 mins):Latest Southern Ocean research shows continuing deep ocean change 2Latest Southern Ocean research shows continuing deep ocean change 3AAPS National Biotechnology Conference to highlight innovative vaccines 2Songbirds' learning hub in brain offers insight into motor control 2Songbirds' learning hub in brain offers insight into motor control 3Keryx Biopharmaceuticals to Present at BioCenturys NewsMakers in the Biotech Industry Conference 11873 1Keryx Biopharmaceuticals to Present at BioCenturys NewsMakers in the Biotech Industry Conference 11873 2iGPS Announces iGPS bios u2122 a New Pallet Rental Service Designed Exclusively for the Pharmaceutical and Life Sciences Industries 11869 1iGPS Announces iGPS bios u2122 a New Pallet Rental Service Designed Exclusively for the Pharmaceutical and Life Sciences Industries 11869 2iGPS Announces iGPS bios u2122 a New Pallet Rental Service Designed Exclusively for the Pharmaceutical and Life Sciences Industries 11869 3Major component in turmeric enhance effect of chemotherapy drug in head and neck cancer 15966 1Major component in turmeric enhance effect of chemotherapy drug in head and neck cancer 15966 2Major component in turmeric enhance effect of chemotherapy drug in head and neck cancer 15966 3
... research in an animal model suggests that a diet ... variety of processed foods including meats, cheeses, beverages, and ... and may even contribute to the development of those ... study also suggests that dietary regulation of inorganic phosphates ...
... 12 WCC Smart Search & Match,the leading ... that Rudie Lion has joined the company as ... brings more than 15 years of product and ... market introduction efforts,for many high-tech products and solutions ...
... can halt the might of a tsunami are false and ... There are many reasons for preserving the world,s dwindling stocks ... of them, they say. , On the eve ... which claimed nearly a quarter of a million lives around ...
Other Biology News:Common food additive found to increase risk and speed spread of lung cancer 2Common food additive found to increase risk and speed spread of lung cancer 3Trees won't stop tsunamis, scientists warn 2Trees won't stop tsunamis, scientists warn 3